908 Devices Inc (MASS)
3.50
+0.02
(+0.57%)
USD |
NASDAQ |
Oct 04, 16:00
3.49
-0.01
(-0.29%)
After-Hours: 20:00
908 Devices SG&A Expense (Annual): 46.18M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 46.18M |
December 31, 2022 | 43.88M |
December 31, 2021 | 32.24M |
Date | Value |
---|---|
December 31, 2020 | 12.50M |
December 31, 2019 | 11.29M |
December 31, 2018 | 9.304M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
11.29M
Minimum
2019
46.18M
Maximum
2023
29.22M
Average
32.24M
Median
2021
SG&A Expense (Annual) Benchmarks
Teleflex Inc | 929.87M |
Perspective Therapeutics Inc | 21.06M |
Retractable Technologies Inc | 20.01M |
Xtant Medical Holdings Inc | 64.29M |
Catheter Precision Inc | 17.12M |